Thema
Antibodies, Monoclonal, Humanized
55.182
Journal Article
45.970
Antibodies, Monoclonal
23.447
Research Support, Non-U.S. Gov't
16.689
Review
9.826
Case Reports
8.670
Bevacizumab
8.116
2S9ZZM9Q9V
8.103
Antineoplastic Agents
7.956
EC 2.7.10.1
6.992
Letter
6.320
Angiogenesis Inhibitors
6.306
Trastuzumab
5.362
P188ANX8CK
5.349
Randomized Controlled Trial
4.953
Multicenter Study
4.822
Vascular Endothelial Growth Factor A
4.024
pembrolizumab
3.917
DPT0O3T46P
3.895
Receptor, ErbB-2
3.833
Comment
3.811
Adalimumab
3.578
FYS6T7F842
3.561
tocilizumab
3.251
I031V2H011
3.240
Research Support, N.I.H., Extramural
3.207
Cetuximab
3.185
PQX0D8J21J
3.170
Comparative Study
2.919
Clinical Trial, Phase II
2.865
Antirheumatic Agents
2.822
Immunosuppressive Agents
2.785
Tumor Necrosis Factor-alpha
2.778
Immunoglobulin G
2.525
ErbB Receptors
2.334
Antineoplastic Agents, Immunological
2.155
Infliximab
2.050
B72HH48FLU
2.033
Clinical Trial, Phase III
2.014
Ranibizumab
1.920
ZL1R02VT79
1.918
Alemtuzumab
1.772
3A189DH42V
1.770
VEGFA protein, human
1.674
Klinische Studie
1.639
ERBB2 protein, human
1.608
Clinical Trial, Phase I
1.562
Anti-Inflammatory Agents
1.552
Fluorouracil
1.527
U3P01618RT
1.527
mehr ...